Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E MacIntyre

Showing results (221-230 of 294) with videos related to

Pageof 30
Sort By:
Journal of Medicinal Chemistry|May 1, 1989
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesisM L Hammond, I E Kopka, R A Zambias, et al.
British Journal of Haematology|November 1, 1996
p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literatureJ F Lesesve, X Troussard, C Bastard, et al.
Blood|November 15, 1996
High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemiaF Davi, K Maloum, A Michel, et al.
Blood|September 9, 2000
The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotypeC Brumpt, E Delabesse, K Beldjord, et al.
Leukemia|August 11, 2006
Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapyL Lhermitte, A de Labarthe, C Dupret, et al.
Molecular Pharmacology|July 1, 1991
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsJ F Evans, C Lévillé, J A Mancini, et al.
Leukemia|February 16, 2017
CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesisG Cordonnier, A Mandoli, A Radhouane, et al.
British Journal of Haematology|March 1, 1996
Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotypeV Andrieu, I Radford-Weiss, X Troussard, et al.
British Journal of Haematology|February 1, 1996
Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantationA Buzyn-Veil, C Belanger, F Audat, et al.
Leukemia|March 17, 2006
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemiaV Asnafi, M-T Rubio, E Delabesse, et al.
Pageof 30

Showing results (221-230 of 294) with videos related to

Sort By:
Pageof 30
Journal of Medicinal Chemistry|May 1, 1989
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesisM L Hammond, I E Kopka, R A Zambias, et al.
British Journal of Haematology|November 1, 1996
p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literatureJ F Lesesve, X Troussard, C Bastard, et al.
Blood|November 15, 1996
High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemiaF Davi, K Maloum, A Michel, et al.
Blood|September 9, 2000
The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotypeC Brumpt, E Delabesse, K Beldjord, et al.
Leukemia|August 11, 2006
Most immature T-ALLs express Ra-IL3 (CD123): possible target for DT-IL3 therapyL Lhermitte, A de Labarthe, C Dupret, et al.
Molecular Pharmacology|July 1, 1991
5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitorsJ F Evans, C Lévillé, J A Mancini, et al.
Leukemia|February 16, 2017
CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesisG Cordonnier, A Mandoli, A Radhouane, et al.
British Journal of Haematology|March 1, 1996
Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotypeV Andrieu, I Radford-Weiss, X Troussard, et al.
British Journal of Haematology|February 1, 1996
Sustained complete cytologic and molecular remission induced by donor leucocyte infusions alone in an acute myeloblastic leukaemia in relapse after bone marrow transplantationA Buzyn-Veil, C Belanger, F Audat, et al.
Leukemia|March 17, 2006
Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemiaV Asnafi, M-T Rubio, E Delabesse, et al.
Pageof 30